Drawing for TRACKER

USPTO serial 97229495

TRACKER

Reviewed by CopyMark Law Group

Reg. 7476676Status 700Registered
Filing date
Status date
Registration date
Aug 13, 2024
Examiner
ALBANO, ASHLEY C
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRACKER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas R. Wolf

Douglas R. Wolf WOLF GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
010Diagnostic kits comprising of collection containers and tools in the nature of blood sample tubes and vials, storage for collecting and shipping bodily fluids and tissue samples for use in disease testing, and test tubesACTIVE—
042providing an online internet website portal featuring links to scientific research data and information in the field of disease treatment and diagnosis and clinical trials; providing collected and analyzed medical and scientific research information in the field of genomics and medical treatmentACTIVE—
044genomic and molecular medical testing for cancer and other cancer diagnostic, monitoring, detection or treatment purposes; diagnostic services, namely, medical diagnostic testing for cancer or other diseases and disorders; providing medical information in the field of genetics and treatment information for cancer and other diseases and disorders for cancer diagnostic, monitoring, detection or treatment purposes; providing medical data and information to healthcare and cancer research professionalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 13, 2024NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 13, 2024R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Jul 8, 2024CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
May 23, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 21, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 21, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 9, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 20, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 8, 2024AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Feb 7, 2024CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Feb 7, 2024IUAAUSE AMENDMENT ACCEPTED—
Jan 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 6, 2024AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Jan 6, 2024IUAFUSE AMENDMENT FILED—
Jan 5, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 5, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 5, 2024EAAUTEAS AMENDMENT OF USE RECEIVED—
Oct 4, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Oct 4, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 13, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 13, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 13, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 9, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2022DOCKASSIGNED TO EXAMINER—
Mar 8, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 8, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 8, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 24, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance